Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Oncology

Diagnostics Companion diagnostics

Atezolizumab Assay Angst

| David Rimm

David Rimm continues the conversation about the best assay for atezolizumab after a recent response to his original article

Subspecialties Neurology

Predicting Prognosis in Glioblastoma

| Luke Turner

A link between cfDNA concentration and progression-free survival in glioblastoma patients supports the use of liquid biopsy when predicting prognosis

Inside the Lab Microscopy and imaging

The Innovators 2019

Leading industry innovators showcase their newest and most advanced solutions for pathology and laboratory medicine

Inside the Lab Technology and innovation

Inspiring Inventions

| Michael Schubert

The inventors of new diagnostic technologies discuss their innovations and how they can move laboratory medicine forward

Diagnostics Biochemistry and molecular biology

Cancer Trap

| Luke Turner

New synthetic scaffolds that sit under the skin and attract cancer cells could provide the earliest indication of metastasis

Diagnostics Biochemistry and molecular biology

Quick Hits

| Luke Turner

Read these bite-size breakthroughs to discover the latest research in the field of diagnostic medicine

Subspecialties Histology

Molecular Drivers of Mesothelioma

| Stefania Erra, Carolina Pelazza

A case series that explores the potential molecular contributors to pleural mesothelioma carcinogenesis – and its treatment options

Subspecialties Oncology

Beating the Biopsy

| Michael Schubert

A new approach to prostate cancer testing aims to decrease unnecessary biopsies and reduce over-treatment

Diagnostics Genetics and epigenetics

On NTRK and Other Fusion Biomarkers

| Fernando Lopez-Rios

Next-generation sequencing is changing the future of precision oncology with its ability to test for NTRK gene fusions and more

Diagnostics Precision medicine

Deep Bio’s Deep Dive

| Sponsored by Deep Bio

AI diagnostics offer great potential for the future – and as a disease of many challenges, prostate cancer is a great first target


Sister Publications

You might be interested in our Sister Publications:

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register